Issued Patents All Time
Showing 1–25 of 54 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11912766 | Anti-Siglec-7 antibodies having reduced effector function | Wouter Korver, Nenad TOMASEVIC | 2024-02-27 |
| 11773162 | Anti-Siglec-7 antibodies for the treatment of cancer | Wouter Korver, Nenad TOMASEVIC, Suzy El Bader, Kenneth Luehrsen | 2023-10-03 |
| 11203638 | Methods and compositions for treating perennial allergic conjunctivitis and keratoconjunctivitis | Bradford Andrew YOUNGBLOOD, Nenad TOMASEVIC | 2021-12-21 |
| 10919983 | Immunoglobulin variable region cassette exchange | Kenneth Luehrsen, Geoffrey T. Yarranton | 2021-02-16 |
| 10774145 | Methods and compositions for treating fibrotic diseases | Nenad TOMASEVIC, Rustom FALAHATI, Bradford Andrew YOUNGBLOOD | 2020-09-15 |
| 10604577 | Methods and compositions for treating systemic mastocytosis | Nenad TOMASEVIC, Rustom FALAHATI | 2020-03-31 |
| 10183996 | Methods and compositions for treating Siglec-8 associated diseases | Nenad TOMASEVIC, Rustom FALAHATI | 2019-01-22 |
| 9546215 | Anti-Siglec-8 antibodies and methods of use thereof | Rustom FALAHATI, Carolina Rita SOUSA FERNANDES, David Matthews, Nenad TOMASEVIC, Jason WILLIAMS +1 more | 2017-01-17 |
| 9290571 | Antibodies to EphA3 | Kenneth Luehrsen, David Martinez, Christina Yi, Geoffrey T. Yarranton | 2016-03-22 |
| 9127046 | Secretion of antibodies without signal peptides from bacteria | Geoffrey T. Yarranton | 2015-09-08 |
| 9109032 | Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow | Geoffrey T. Yarranton, Varghese Palath, Mark Baer | 2015-08-18 |
| 9045539 | Anti-EMR1 antibodies | Kenneth Luehrsen, Mark Baer, David Martinez, Varghese Palath, Swathi Sujatha-Bhaskar +3 more | 2015-06-02 |
| 9017674 | Antibodies to granulocyte-macrophage colony-stimulating factor | Kenneth Luehrsen, Geoffrey T. Yarranton | 2015-04-28 |
| 8877191 | Antibodies to the PcrV antigen of Pseudomonas aeruginosa | Kenneth Luehrsen, Geoffrey T. Yarranton, Mark Baer | 2014-11-04 |
| 8834870 | Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3 | Geoffrey T. Yarranton, Varghese Palath | 2014-09-16 |
| 8828393 | Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist | Lesley Pickford, Geoffrey T. Yarranton, David J. King | 2014-09-09 |
| 8758757 | Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) | Josephine M. Cardarelli, Tseng-hui Timothy Chen, David J. King, Sarah L. Pogue, Francis Joseph Carr +1 more | 2014-06-24 |
| 8664365 | Antibodies to EphA3 | Kenneth Luehrsen, David Martinez, Christina Yi, Geoffrey T. Yarranton | 2014-03-04 |
| 8637016 | EphA3 antibodies for the treatment of solid tumors | Martin Lackmann, Andrew Scott, Geoffrey T. Yarranton, Carmelina Murone, Catherine To | 2014-01-28 |
| 8398972 | Methods of treating dementia using a GM-CSF antagonist | Geoffrey T. Yarranton, Varghese Palath | 2013-03-19 |
| 8354251 | Transactivation system for mammalian cells | Bo Yu | 2013-01-15 |
| 8211648 | Secretion of antibodies without signal peptides from bacteria | Geoffrey T. Yarranton | 2012-07-03 |
| 8168183 | Antibodies to granulocyte-macrophage colony-stimulating factor | Kenneth Luehrsen, Geoffrey T. Yarranton | 2012-05-01 |
| 8084249 | Vector | Susan Kingsman, Fiona Ellard, Miles Carroll, Kevin Myers | 2011-12-27 |
| 8075885 | Methods of treating heart failure using an anti-GM-CSF antibody | Geoffrey T. Yarranton | 2011-12-13 |